-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R0LvqXvh4a28d9xfevCy7nrGH45WeiR1B+3vYgFViNVesEOzW5DuPd6XkOJD3ye/ 0XEYDm15yTqtDz2sj8ac2g== 0001012870-02-002875.txt : 20020628 0001012870-02-002875.hdr.sgml : 20020628 20020628161735 ACCESSION NUMBER: 0001012870-02-002875 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20020416 ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20020628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BLUE MARTINI SOFTWARE INC CENTRAL INDEX KEY: 0001077814 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 943319751 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-30925 FILM NUMBER: 02691676 BUSINESS ADDRESS: STREET 1: 2600 CAMPUS DR STREET 2: SUITE 175 CITY: SAN MATEO STATE: CA ZIP: 94403 8-K/A 1 d8ka.htm FORM 8-K/A Prepared by R.R. Donnelley Financial -- Form 8-K/A
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K/A
 
Amended Current Report
 
Pursuant to Section 13 or 15(d)
of the
Securities Exchange Act of 1934
 
Date of earliest event reported
April, 16, 2002
 

 
BLUE MARTINI SOFTWARE, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
0-30925
 
94-3319751
(State or other jurisdiction of
incorporation or organization)
 
(Commission File No.)
 
(I.R.S. Employer
Identification No.)
 
2600 Campus Drive
San Mateo, California 94403
(Address of principal executive offices)
 
Telephone Number (650) 356-4000
(Registrant’s telephone number, including area code)
 


 
On May 1, 2002, Blue Martini Software, Inc. (“Blue Martini”) filed a Current Report on Form 8-K to report its acquisition of The Cybrant Corporation (“Cybrant”) on April 16, 2002. Pursuant to Item 7 of Form 8-K, Blue Martini indicated that it would file certain financial information under Item 7 of Form 8-K no later than the date required. This Amendment is filed to provide the required financial information and to amend the language of Sections (a), (b), and (c) of Item 7.
 
Item 7.    Financial Statements, Pro Forma Financial Information and Exhibits
 
(a)  Financial Statements of Business Acquired.
 
The required financial statements of Cybrant have been included in exhibit 99.2 of this Amendment.
 
(b)  Pro Forma Financial Information.
 
 
(c)  Exhibits.
 
 
Item No.

  
Description

    2.1*
  
Agreement and Plan of Merger and Reorganization, dated as of April 16, 2002.
23.1
  
Consent of PricewarterhouseCoopers LLP (Independent Accountants for Cybrant).
  99.1*
  
Blue Martini Press Release dated April 16, 2002.
99.2
  
Cybrant audited financial statements for the years ended December 31, 2000 and 2001.

*
 
Previously Filed as exhibits to our Current Report on Form 8-K filed with the Commission on May 1, 2002, and incorporated herein by reference.

2


 
BLUE MARTINI SOFTWARE
 
 
On April 16, 2002, Blue Martini Software, Inc. (“Blue Martini”) completed the acquisition of the Cybrant Corporation (“Cybrant”), through the merger of a wholly owned subsidiary of Blue Martini with and into Cybrant, with Cybrant surviving as a wholly owned subsidiary of Blue Martini (the “Merger”).
 
The following unaudited pro forma combined condensed financial information has been prepared to give effect to the Merger. This financial information reflects certain assumptions deemed probable by management regarding the Merger. The total estimated purchase consideration of the Merger has been allocated on a preliminary basis to assets and liabilities based on management’s best estimates of their fair value with the excess cost over the net assets acquired allocated to goodwill. The adjustments to the unaudited pro forma combined condensed financial information are subject to change pending a final analysis of the total purchase cost and the fair value of the assets and liabilities assumed. The impact of these changes could be material.
 
The unaudited pro forma combined condensed balance sheet as of December 31, 2001 gives effect to the Merger as if it had occurred on December 31, 2001, and combines the historical consolidated balance sheet of Blue Martini and the historical balance sheet of Cybrant as of that date.
 
The unaudited pro forma combined condensed statement of operations for the year ended December 31, 2001 combines the historical consolidated statement of operations of Blue Martini for the year ended December 31, 2001 with the historical statement of operations of Cybrant for the year ended December 31, 2001, and assumes that the merger had occurred on January 1, 2001.
 
The unaudited pro forma combined condensed financial information is based on estimates and assumptions. These estimates and assumptions are preliminary and have been made solely for purposes of developing this pro forma information. Unaudited pro forma combined condensed financial information is presented for illustrative purposes only and is not necessarily indicative of the combined financial position or results of operations of future periods or the results that actually would have been realized had the entities been a single entity during this period. This unaudited pro forma combined financial information is based upon the respective historical consolidated financial statements of Blue Martini and notes thereto, previously filed with the Securities and Exchange Commission and the historical financial statements of Cybrant included in this Form 8-K/A, and should be read in conjunction with those statements and the related notes.

3


 
BLUE MARTINI SOFTWARE, INC.
 
December 31, 2001
(In thousands)
 
    
Blue Martini

    
Cybrant

    
Pro Forma Adjustment

      
Pro Forma Combined

 
ASSETS
                                     
Current assets:
                                     
Cash and cash equivalents
  
$
12,945
 
  
$
1,744
 
             
$
14,689
 
Short-term investments
  
 
84,554
 
  
 
—  
 
             
 
84,554
 
Accounts receivable, net
  
 
5,558
 
  
 
1,506
 
             
 
7,064
 
Prepaids and other current assets
  
 
2,370
 
  
 
1,179
 
  
 
(89
)(A)
    
 
3,460
 
    


  


  


    


Total current assets
  
 
105,427
 
  
 
4,429
 
  
 
(89
)
    
 
109,767
 
Long-term investments
  
 
—  
 
  
 
—  
 
             
 
—  
 
Property and equipment, net
  
 
4,654
 
  
 
1,724
 
  
 
(1,586
)(A)
    
 
4,792
 
Intangible assets and other, net
  
 
12,340
 
  
 
164
 
  
 
2,700
(A)
    
 
15,204
 
Goodwill
  
 
—  
 
  
 
—  
 
  
 
4,567
(A)
    
 
4,567
 
    


  


  


    


Total assets
  
$
122,421
 
  
$
6,317
 
  
$
5,592
 
    
$
134,330
 
    


  


  


    


LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ DEFICIT
                                     
Current liabilities:
                                     
Accounts payable
  
$
1,848
 
  
$
208
 
             
$
2,056
 
Accrued liabilities and other current liabilities
  
 
12,940
 
  
 
1,927
 
  
 
552
(A)
    
 
15,419
 
Deferred revenues
  
 
5,061
 
  
 
1,000
 
  
 
(802
)(A)
    
 
5,259
 
Long-term obligations-current
  
 
110
 
  
 
1,668
 
  
 
96
(A)
    
 
1,874
 
    


  


  


    


Total current liabilities
  
 
19,959
 
  
 
4,803
 
  
 
(154
)
    
 
24,608
 
Long-term obligations-non current
  
 
—  
 
  
 
218
 
             
 
218
 
    


  


  


    


Total liabilities
  
 
19,959
 
  
 
5,021
 
  
 
(154
)
    
 
24,826
 
    


  


  


    


Redeemable convertible preferred stock,
  
 
—  
 
  
 
37,178
 
  
 
(37,178
)(A)
    
 
—  
 
    


  


  


    


Stockholders’ deficit:
                                     
Common stock
  
 
68
 
  
 
2
 
  
 
(2
)(A)
    
 
68
 
Additional paid-in-capital
  
 
253,946
 
  
 
2,770
 
  
 
5,165
(A)
    
 
261,881
 
Deferred stock compensation
  
 
(8,000
)
           
 
—  
 
    
 
(8,000
)
Notes receivable from stockholders
  
 
—  
 
  
 
(93
)
             
 
(93
)
Accum. other comprehensive income
  
 
595
 
  
 
—  
 
  
 
—  
 
    
 
595
 
Accumulated deficit
  
 
(144,147
)
  
 
(38,561
)
  
 
37,761
(A)
    
 
(144,947
)
    


  


  


    


Total stockholders’ deficit
  
 
102,462
 
  
 
(35,882
)
  
 
42,924
 
    
 
109,504
 
    


  


  


    


Total liabilities, redeemable convertible preferred stock and stockholders’ deficit
  
$
122,421
 
  
$
6,317
 
  
$
5,592
 
    
$
134,330
 
    


  


  


    


 
 
See accompanying Notes to Unaudited Pro Forma Combined Condensed Financial Statements.

4


BLUE MARTINI SOFTWARE, INC.
 
For the Year Ended December 31, 2001
(In thousands, except per share data)
 
    
Blue Martini

    
Cybrant

    
Pro Forma
Adjustments

    
Pro Forma
Combined

 
Revenues:
                                   
License
  
$
20,438
 
  
$
4,074
 
           
$
24,512
 
Service
  
 
39,476
 
  
 
3,902
 
           
 
43,378
 
    


  


  


  


Total revenues
  
 
59,914
 
  
 
7,976
 
  
 
—  
 
  
 
67,890
 
    


  


  


  


Cost of revenues:
                                   
License
  
 
2,122
 
  
 
1,000
 
           
 
3,122
 
Service
  
 
37,359
 
  
 
5,297
 
           
 
42,656
 
Amortization of purchased technology
  
 
2,000
 
           
 
1,200
(B)
  
 
3,200
 
    


  


  


  


Total cost of revenues
  
 
41,481
 
  
 
6,297
 
  
 
1,200
 
  
 
48,978
 
    


  


  


  


Gross profit
  
 
18,433
 
  
 
1,679
 
  
 
(1,200
)
  
 
18,912
 
    


  


  


  


Operating expenses:
                                   
Sales and marketing
  
 
46,661
 
  
 
8,041
 
           
 
54,702
 
Research & development
  
 
18,623
 
  
 
7,066
 
           
 
25,689
 
General & administrative
  
 
10,900
 
  
 
1,243
 
           
 
12,143
 
Charges for stock compensation
  
 
12,014
 
  
 
—  
 
           
 
12,014
 
Amortization of acquired other intangibles
                    
 
150
(B)
  
 
150
 
Restructuring charges
  
 
6,257
 
  
 
—  
 
           
 
6,257
 
    


  


  


  


Total operating expenses
  
 
94,455
 
  
 
16,350
 
  
 
150
 
  
 
110,955
 
    


  


  


  


Loss from operations
  
 
(76,022
)
  
 
(14,671
)
  
 
(1,350
)
  
 
(92,043
)
Interest & other, net
  
 
6,418
 
  
 
(5
)
           
 
6,413
 
    


  


  


  


Net loss
  
$
(69,604
)
  
$
(14,676
)
  
$
(1,350
)
  
$
(85,630
)
    


  


  


  


Basic and diluted net loss per common share
  
$
(1.09
)
                    
$
(1.25
)
    


                    


Shares used in computing basic and diluted net loss per common share
  
 
63,970
 
           
 
4,535
 
  
 
68,505
 
    


           


  


 
 
See accompanying Notes to Unaudited Pro Forma Combined Condensed Financial Statements.

5


 
BLUE MARTINI SOFTWARE, INC.
 
 
(A)  To record the application of the purchase accounting.
 
The total estimated purchase price is $8,487,000 and is comprised of:
 
1.  The issuance of 4,534,936 shares of Blue Martini common stock to Cybrant shareholders. The fair value of the Blue Martini shares issued is based on a per share value of $1.58, which is equal to the average market price as reported on the Nasdaq National Market for the period from two days prior to two days subsequent to the public announcement of the merger.
 
2.  The exchange of warrants assumed in the Merger for 586,762 shares of Blue Martini common stock with an exercise price of $0.79 per share that expire in 2007. The warrants have been valued based on the Black-Scholes option pricing model.
 
3.  Estimated restructuring and exit costs consisting primarily of severance payments, facility and equipment related charges.
 
4.  Estimated direct costs of the transactions consisting primarily of fees for legal, accounting and valuation services.
 
The amounts and components of the estimated purchase price is presented below (in thousands):
 
Fair value of Blue Martini common stock issued
  
$
7,165
Estimated fair value of warrants exchanged
  
 
770
Estimated restructuring and exit costs
  
 
352
Estimated acquisition-related costs
  
 
200
    

    
$
8,487
    

 
Under purchase accounting, the total purchase price will be allocated to Cybrant’s assets and liabilities based on their fair values. Allocations are subject to valuations as of the date of the consummation of the merger. The total price is expected to be allocated to tangible assets and liabilities, identifiable intangible assets, including in-process research and development (“IPRD”) and purchased technology, and goodwill. The purchased technology is expected to be amortized over two years beginning at acquisition date and the IPRD will be charged to expense in the second quarter of 2002.
 
The following represents the preliminary allocation of the purchase price to the acquired assets and assumed liabilities of Cybrant. The allocation is preliminary and based on Cybrant’s assets and liabilities as of December 31, 2001 (in thousands):
 
Net assets assumed
  
$
420
Purchased technology
  
 
2,400
Other intangible assets
  
 
300
Goodwill
  
 
4,567
In-process research and development
  
 
800
    

Total purchase price
  
$
8,487
    

 
The actual allocation of the purchase price will be based on the composition of Cybrant’s net assets on April 16, 2002 (the Merger closing date) and the final valuation analysis of the fair value of the net assets as of April 16, 2002. Consequently, the actual allocation of the purchase price could differ from that presented above.
 
Net assets assumed were adjusted primarily for the adjustments of certain fixed assets to fair values, the reduction of deferred revenue to the fair value of the obligation assumed and additional liabilities in connection with payoff of certain lease obligations.
 
Goodwill represents the excess of the purchase price over the fair value of the tangible and identifiable assets. The unaudited pro forma combined statement of operations does not include the amortization of goodwill acquired in the acquisition in accordance with Financial Accounting Standards Board Statement No. 142, Goodwill and Other Intangible Assets.
 
(B)  Acquired intangible assets are amortized over a period of two years.

6


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
BLUE MARTINI SOFTWARE , INC.
By:
 
/s/    ROBERT E. CELL        

   
Robert E. Cell
Vice President and Chief Financial Officer
Dated: June 26, 2002

7


EXHIBIT INDEX
 
Exhibit Number

   
Description

2.1
*
 
Agreement and Plan of Merger and Reorganization, dated as of April 16, 2002.
23.1
 
 
Consent of PricewarterhouseCoopers LLP (Independent Accountants for Cybrant).
99.1
*
 
Blue Martini Press Release dated April 16,2002.
99.2
 
 
The Cybrant Corp. audited financial statements for the years ended December 31, 2000 and 2001.

*
 
Previously Filed as Exhibits to our Current Report on Form 8-K filed with the Commission on May 1, 2002
EX-23.1 3 dex231.htm CONSENT OF PRICEWATERHOUSECOOPERS LLP Prepared by R.R. Donnelley Financial -- Consent of PricewaterhouseCoopers LLP
 
EXHIBIT 23.1
 
CONSENT OF INDEPENDENT ACCOUNTANTS
 
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-42388, 333-55374 and 333-82928) of Blue Martini Software, Inc. of our report dated March 29, 2002, except for Note 13, which is as of April 16, 2002, relating to the financial statements of The Cybrant Corporation, which appears in the Current Report on Form 8-K/A of Blue Martini Software, Inc. dated April 16, 2002.
 
/S/    PRICEWATERHOUSECOOPERS LLP
 
San Jose, California
June 26, 2002
EX-99.2 4 dex992.htm THE CYBRANT COR. AUDITED FINANCIAL STATEMENTS Prepared by R.R. Donnelley Financial -- The Cybrant Cor. audited financial statements
Exhibit 99.2
 
The Cybrant Corporation
Financial Statements
For the Years Ended
December 31, 2001 and 2000


 
Report of Independent Accountants
 
To the Board of Directors and Stockholders
of The Cybrant Corporation
 
In our opinion, the accompanying balance sheets and the related statements of operations, of redeemable convertible preferred stock and stockholders’ deficit and of cash flows present fairly, in all material respects, the financial position of The Cybrant Corporation (the “Company”) as of December 31, 2001 and 2000, and the results of its operations and its cash flows for the years ended December 31, 2001 and 2000, in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management; our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States of America, which require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
 
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, the Company has incurred losses from operations since its inception, and negative cash flows from operations in every fiscal period, has a net stockholders’ deficit and limited capital. These circumstances raise substantial doubt about its ability to continue as a going concern. Management’s plan in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
 
 
 
March 29, 2002, except for Note 13,
/s/    PRICEWATERHOUSECOOPERS LLP
which is as of April 16, 2002


 
The Cybrant Corporation
Balance Sheets

 
    
December 31,

 
    
2001

    
2000

 
Assets
                 
Current assets:
                 
Cash and cash equivalents
  
$
1,743,918
 
  
$
12,146,618
 
Accounts receivable, net
  
 
1,506,133
 
  
 
2,461,169
 
Prepaid expenses and other current assets
  
 
1,179,166
 
  
 
383,728
 
    


  


Total current assets
  
 
4,429,217
 
  
 
14,991,515
 
Property and equipment, net
  
 
1,724,298
 
  
 
3,092,486
 
Other assets
  
 
163,483
 
  
 
274,106
 
Restricted cash
  
 
—  
 
  
 
976,000
 
    


  


Total assets
  
$
6,316,998
 
  
$
19,334,107
 
    


  


Liabilities, Redeemable Convertible Preferred Stock and Stockholders’ Deficit
                 
Current liabilities:
                 
Accounts payable
  
$
207,755
 
  
$
829,335
 
Accrued liabilities
  
 
1,927,128
 
  
 
1,730,270
 
Deferred revenue
  
 
1,000,054
 
  
 
1,702,878
 
Capital leases, current
  
 
226,995
 
  
 
199,014
 
Lines of credit, current
  
 
1,440,530
 
  
 
720,518
 
    


  


Total current liabilities
  
 
4,802,462
 
  
 
5,182,015
 
Accrued rent
  
 
144,267
 
  
 
99,484
 
Capital leases, noncurrent portion
  
 
74,249
 
  
 
283,905
 
Lines of credit, noncurrent
  
 
—  
 
  
 
1,441,600
 
    


  


Total liabilities
  
 
5,020,978
 
  
 
7,007,004
 
    


  


Commitments (Note 6)
                 
Redeemable convertible preferred stock, par value $0.0001,
179,369,228 and 23,869,228 shares authorized as of December 31, 2001 and 2000, respectively;
70,693,165 and 20,545,478 shares issued and outstanding as of December 31, 2001 and 2000, respectively;
(aggregate liquidation preference of $42,581,890 as of December 31, 2001)
  
 
37,178,193
 
  
 
33,774,872
 
Stockholders’ deficit:
                 
Common stock, par value $0.0001, 220,000,000 and 52,330,772 shares authorized as of December 31, 2001 and 2000, respectively; 19,913,314 and 19,338,825 shares issued and outstanding as of December 31, 2001 and 2000, respectively
  
 
1,992
 
  
 
1,934
 
Additional paid-in capital
  
 
876,096
 
  
 
836,542
 
Notes receivable from stockholders
  
 
(92,558
)
  
 
(294,923
)
Accumulated deficit
  
 
(36,667,703
)
  
 
(21,991,322
)
    


  


Total stockholders’ deficit
  
 
(35,882,173
)
  
 
(21,447,769
)
    


  


Total liabilities, redeemable convertible preferred stock and stockholders’ deficit
  
$
6,316,998
 
  
$
19,334,107
 
    


  


 
The accompanying notes are an integral part of these financial statements.


 
The Cybrant Corporation
Statements of Operations

 
    
Year Ended December 31,

 
    
2001

    
2000

 
Revenues:
                 
License
  
$
4,074,348
 
  
$
1,753,260
 
Service
  
 
3,901,346
 
  
 
1,209,942
 
    


  


Total revenues
  
 
7,975,694
 
  
 
2,963,202
 
    


  


Cost of sales:
                 
License
  
 
1,000,000
 
  
 
250,001
 
Service
  
 
5,296,947
 
  
 
4,982,991
 
    


  


Total cost of sales
  
 
6,296,947
 
  
 
5,232,992
 
    


  


Gross profit/(loss)
  
 
1,678,747
 
  
 
(2,269,790
)
    


  


Operating expenses:
                 
Research and development
  
 
7,065,734
 
  
 
7,576,957
 
Sales and marketing
  
 
8,041,405
 
  
 
9,940,559
 
General and administrative
  
 
1,242,605
 
  
 
1,285,799
 
    


  


Total operating expenses
  
 
16,349,744
 
  
 
18,803,315
 
    


  


Loss from operations
  
 
(14,670,997
)
  
 
(21,073,105
)
Interest income
  
 
258,682
 
  
 
800,520
 
Interest expense
  
 
(264,066
)
  
 
(48,544
)
    


  


Net loss
  
$
(14,676,381
)
  
$
(20,321,129
)
    


  


 
The accompanying notes are an integral part of these financial statements.


 
The Cybrant Corporation
Statement of Redeemable Convertible Preferred Stock and Stockholders’ Deficit
For the Years Ended December 31, 2001 and 2000

 
   
Redeemable Convertible Preferred Stock

 
Common Stock

    
Additional Paid-In Capital

    
Notes Receivable from Stockholders

   
Accumulated
Deficit

   
Total

 
   
Shares

 
Amount

 
Shares

    
Amount

           
Balance at December 31, 1999
 
10,769,228
 
$
2,765,000
 
15,960,000
 
  
$
1,596
 
  
$
47,904
 
  
$
(46,507
)
 
$
(1,670,193
)
 
$
(1,667,200
)
Issuance of Series B redeemable convertible preferred stock, net of issuance costs of $24,037 for cash in January 2001
 
6,134,322
 
 
17,053,302
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
 
 
—  
 
 
 
—  
 
Issuance of warrants to purchase Series B redeemable convertible preferred stock in conjunction with a lease of office space in March 2000
 
—  
 
 
—  
 
—  
 
  
 
—  
 
  
 
24,175
 
  
 
—  
 
 
 
—  
 
 
 
24,175
 
Issuance of Series C redeemable convertible preferred stock, net of issuance costs of $49,557 for cash and receivables from August through November 2000
 
3,641,928
 
 
13,956,570
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
(176,149
)
 
 
—  
 
 
 
(176,149
)
Issuance of warrants to purchase Series C redeemable convertible preferred stock in conjunction with a capital lease in September 2000
 
—  
 
 
—  
 
—  
 
  
 
—  
 
  
 
120,707
 
  
 
—  
 
 
 
—  
 
 
 
120,707
 
Issuance of common stock pursuant to the exercise of stock options from January through November 2000
 
—  
 
 
—  
 
3,495,700
 
  
 
350
 
  
 
557,037
 
  
 
(66,400
)
 
 
—  
 
 
 
490,987
 
Repurchase of common stock upon the termination of employees from July through November 2000
 
—  
 
 
—  
 
(116,875
)
  
 
(12
)
  
 
(35,157
)
  
 
—  
 
 
 
—  
 
 
 
(35,169
)
Interest accrued on notes receivable from stockholders
 
—  
 
 
—  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
(5,867
)
 
 
—  
 
 
 
(5,867
)
Issuance of stock options to non-employees in exchange for services from February through October 2000
 
—  
 
 
—  
 
—  
 
  
 
—  
 
  
 
121,876
 
  
 
—  
 
 
 
—  
 
 
 
121,876
 
Net loss
 
—  
 
 
—  
 
—  
 
  
 
—  
 
  
 
—  
 
  
 
—  
 
 
 
(20,321,129
)
 
 
(20,321,129
)
   
 

 

  


  


  


 


 


Balance at December 31, 2000
 
20,545,478
 
 
33,774,872
 
19,338,825
 
  
 
1,934
 
  
 
836,542
 
  
 
(294,923
)
 
 
(21,991,322
)
 
 
(21,447,769
)
 
The accompanying notes are an integral part of these financial statements.


 
The Cybrant Corporation
Statement of Redeemable Convertible Preferred Stock and Stockholders’ Deficit (Continued)
For the Years Ended December 31, 2001 and 2000

 
   
Redeemable Convertible Preferred Stock

   
Common Stock

   
Additional Paid-In Capital

    
Notes Receivable from Stockholders

   
Accumulated
Deficit

   
Total

 
   
Shares

   
Amount

   
Shares

    
Amount

          
Balance at December 31, 2000
 
20,545,478
 
 
 
33,774,872
 
 
19,338,825
 
  
 
1,934
 
 
 
836,542
 
  
 
(294,923
)
 
 
(21,991,322
)
 
 
(21,447,769
)
Exercise of stock options from February 2001 to August 2001
 
—  
 
 
 
—  
 
 
77,542
 
  
 
8
 
 
 
39,254
 
  
 
—  
 
 
 
—  
 
 
 
39,262
 
Issuance of stock options to non-employees in exchange for services from January through April 2001
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
23,747
 
  
 
—  
 
 
 
—  
 
 
 
23,747
 
Repurchase of common stock upon the termination of employees from January 2001 through November 2001
 
—  
 
 
 
—  
 
 
(683,251
)
  
 
(68
)
 
 
(122,770
)
  
 
—  
 
 
 
—  
 
 
 
(122,838
)
Compensation expense for shares repurchased
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
40,431
 
  
 
—  
 
 
 
—  
 
 
 
40,431
 
Repayment of notes receivable
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
—  
 
  
 
209,652
 
 
 
—  
 
 
 
209,652
 
Interest accrued on notes receivable from stockholders
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
—  
 
  
 
(7,287
)
 
 
—  
 
 
 
(7,287
)
Issuance of Series D redeemable convertible preferred stock, net of issuance costs of $169,731 for cash in August 2001
 
13,452,084
 
 
 
3,462,331
 
 
—  
 
  
 
—  
 
 
 
—  
 
  
 
—  
 
 
 
—  
 
 
 
—  
 
Conversion of Series A preferred stock into Series A-1 preferred stock and common stock
 
(46,153
)
 
 
(2,308
)
 
46,153
 
  
 
5
 
 
 
2,303
 
  
 
—  
 
 
 
—  
 
 
 
2,308
 
Conversion of Series B preferred stock into Series B-1 preferred stock, Series B-2 preferred stock and common stock
 
13,550,575
 
 
 
(42,011
)
 
840,220
 
  
 
84
 
 
 
41,927
 
  
 
—  
 
 
 
—  
 
 
 
42,011
 
Conversion of Series C preferred stock into Series C-1 preferred stock, Series C-2 preferred stock and common stock
 
23,191,181
 
 
 
(14,691
)
 
293,825
 
  
 
29
 
 
 
14,662
 
  
 
—  
 
 
 
—  
 
 
 
14,691
 
Allocation of discount on conversion of preferred stock
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
1,893,790
 
  
 
—  
 
 
 
—  
 
 
 
1,893,790
 
Deemed dividend on conversion of preferred stock
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
(1,893,790
)
  
 
—  
 
 
 
—  
 
 
 
(1,893,790
)
Net loss
 
—  
 
 
 
—  
 
 
—  
 
  
 
—  
 
 
 
—  
 
  
 
—  
 
 
 
(14,676,381
)
 
 
(14,676,381
)
   

 


 

  


 


  


 


 


Balance at December 31, 2001
 
70,693,165
 
 
$
37,178,193
 
 
19,913,314
 
  
$
1,992
 
 
$
876,096
 
  
$
(92,558
)
 
$
(36,667,703
)
 
$
(35,882,173
)
   

 


 

  


 


  


 


 


 
The accompanying notes are an integral part of these financial statements.


 
The Cybrant Corporation
Statements Cash Flows

 
    
Year Ended December 31,

 
    
2001

    
2000

 
Cash flows from operating activities:
                 
Net loss
  
$
(14,676,381
)
  
$
(20,321,129
)
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Provision for (recovery of) doubtful accounts
  
 
(48,000
)
  
 
117,925
 
Amortization of deferred warrant costs
  
 
43,689
 
  
 
12,361
 
Depreciation and amortization
  
 
1,438,576
 
  
 
699,376
 
Interest income on notes receivable
  
 
(7,287
)
  
 
(5,867
)
Stock-based compensation for non-employees
  
 
23,747
 
  
 
121,876
 
Compensation expense for repurchase of non-vested common stock
  
 
40,431
 
  
 
—  
 
Loss on disposal of fixed assets
  
 
7,474
 
  
 
—  
 
Changes in operating assets and liabilities:
                 
Accounts receivable
  
 
1,003,036
 
  
 
(2,579,094
)
Prepaid expenses and other current assets
  
 
(795,438
)
  
 
(340,039
)
Other assets
  
 
66,934
 
  
 
(161,229
)
Accounts payable
  
 
(621,580
)
  
 
746,282
 
Accrued liabilities
  
 
196,858
 
  
 
1,653,855
 
Deferred revenue
  
 
(702,824
)
  
 
1,702,878
 
Accrued rent
  
 
44,783
 
  
 
99,484
 
Restricted cash
  
 
976,000
 
  
 
(976,000
)
    


  


Net cash used in operating activities
  
 
(13,009,982
)
  
 
(19,229,321
)
    


  


Cash flows from investing activities:
                 
Purchase of property and equipment
  
 
(77,862
)
  
 
(3,101,119
)
    


  


Net cash used in investing activities
  
 
(77,862
)
  
 
(3,101,119
)
    


  


Cash flows from financing activities:
                 
Proceeds from issuance of common stock
  
 
39,262
 
  
 
490,987
 
Proceeds from redeemable convertible preferred stock
  
 
3,462,331
 
  
 
30,833,723
 
Repurchase of common stock
  
 
(122,838
)
  
 
(35,169
)
Repayment of notes receivable
  
 
209,652
 
  
 
—  
 
Payments of capital lease obligations
  
 
(181,675
)
  
 
(15,467
)
Proceeds from line of credit
  
 
—  
 
  
 
2,329,760
 
Repayment of line of credit
  
 
(721,588
)
  
 
(167,968
)
    


  


Net cash provided by financing activities
  
 
2,685,144
 
  
 
33,435,866
 
    


  


Increase (decrease) in cash and cash equivalents
  
 
(10,402,700
)
  
 
11,105,426
 
Cash and cash equivalents, beginning of period
  
 
12,146,618
 
  
 
1,041,192
 
    


  


Cash and cash equivalents, end of period
  
$
1,743,918
 
  
$
12,146,618
 
    


  


Supplemental disclosures of cash flow information:
                 
Cash paid for interest
  
$
33,024
 
  
$
38,485
 
Supplemental disclosures of non-cash investing and financing activities:
                 
Equipment purchased under capital leases
  
$
—  
 
  
$
475,939
 
Common stock purchased with notes receivable
  
$
—  
 
  
$
66,400
 
Series C stock purchased with notes receivable
  
$
—  
 
  
$
176,149
 
Conversion of Series A to Series A-1
  
$
2,762,692
 
  
$
—  
 
Conversion of Series A to common stock
  
$
2,308
 
  
$
—  
 
Conversion of Series B to Series B-1
  
$
12,714,176
 
  
$
—  
 
Conversion of Series B to Series B-2
  
$
4,297,115
 
  
$
—  
 
Conversion of Series B to common stock
  
$
42,011
 
  
$
—  
 
Conversion of Series C to Series C-1
  
$
12,855,667
 
  
$
—  
 
Conversion of Series C to Series C-2
  
$
1,086,212
 
  
$
—  
 
Conversion of Series C to common stock
  
$
14,691
 
  
$
—  
 
Deemed dividend on conversion of preferred stock
  
$
1,893,790
 
  
$
—  
 
 
The accompanying notes are an integral part of these financial statements.


The Cybrant Corporation
Notes to Financial Statements

 
1.
 
Business Description and Financial Statement Presentation
 
Business description
The Cybrant Corporation (“Cybrant” or the “Company”), was incorporated as eePRISE, Inc., in Delaware on March 4, 1999. The Company changed its name to The Cybrant Corporation on September 27, 1999. Cybrant, headquartered in Mountain View, California, is focused on providing electronic commerce software and services which enables its customers to sell complex products and services externally over the Internet and other platforms and solve complex business problems internally through the use of the software’s solutions architecture.
 
The Company has completed several rounds of private equity financing. However, the Company has incurred substantial losses and negative cash flows from operations since inception. For 2001, the Company incurred a loss of $14,676,381 and negative cash flows from operations of $13,009,982. As of December 31, 2001, the Company has an accumulated deficit of $36,667,703. Management expects operating losses and negative cash flows to continue for the foreseeable future because of additional costs and expenses related to sales, marketing and other promotional activities, continued research and development efforts and development of relationships with other business. Management’s plans with regard to these matters include increasing revenues and reducing operating expenses as well as seeking additional financing or selling the Company (see Note 13). These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
 
2.
 
Summary of Significant Accounting Policies
 
Use of estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
 
Revenue recognition
Revenues are derived from software licenses and related services, which include implementation and integration, technical support, training and consulting. Software license revenues are recognized when persuasive evidence of an arrangement exists, delivery has occurred, no significant Company obligations with regard to implementation or integration exist, the fee is fixed or determinable and collection is reasonably assured as prescribed in SOP No. 97-2, “Software Revenue Recognition.” For arrangements with multiple elements, the total fee from the arrangement is allocated among each element based upon vendor specific objective evidence (“VSOE”) of fair value of each of the undelivered elements. VSOE of fair value for the service elements is based upon the standard hourly rate the Company charges for services when such services are sold separately. VSOE of fair value for annual maintenance is established based upon the original stated renewal rate. When VSOE of fair value exist for all undelivered elements, the Company accounts for the delivered elements, primarily the license portion, based upon the “residual method” as prescribed by SOP No. 98-9, “Modification of SOP 97-2 with Respect to Certain Transactions.” The Company recognizes revenue allocated to maintenance ratably over the contract period, which is generally twelve months.
 
License and service revenue on contracts involving significant implementation, customization or services which are essential to the functionality of the software is recognized, primarily using the percentage-of-completion method. Labor hours incurred is generally used as the measure of progress towards completion. Revenue for these arrangements is classified as license revenue and service revenue based upon estimates of fair value for each element. A provision for estimated losses on engagements is made in the period in which the loss becomes probable and can be reasonably estimated.

1


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Customer billing occurs in accordance with contract terms. Customer advances and amounts billed to customers in excess of revenue recognized are recorded as deferred revenue. Amounts recognized as revenue in advance of billing (typically under percentage-of-completion accounting) are recorded as unbilled receivables.
 
Cash and cash equivalents
The Company considers all highly liquid investments with an original or remaining maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at cost plus accrued interest, which approximates fair market value. Cash equivalents consist of money market instruments and totaled $25,444 and $25,182 at December 31, 2001 and 2000, respectively.
 
Restricted cash
At December 31, 2000, the Company had a cash balance totaling $976,000 in the form of certificates of deposits which were restricted from withdrawal. The total amount served as collateral to letters issued by the bank to the Company’s lessor as security deposit on long term operating lease for facilities. During 2001, the Company did not meet its payment obligation to the Company’s lessor. As a result, the Company’s lessor exercised its right over the restricted cash balance of $976,000. This lease has been subsequently terminated and settled (see Note 13).
 
Fair value of financial instruments
The carrying amounts of the Company’s financial instruments, which include cash equivalents, accounts receivable and accounts payable approximate their fair values due to their short maturities. Based on borrowing rates currently available to the Company for loans with similar terms, the carrying value of notes payable approximates fair value.
 
Concentration of credit risk
Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company places its cash and cash equivalents primarily in checking and money market accounts with financial institutions that management considers creditworthy. The Company performs ongoing credit evaluations of its customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary. To date, such losses have been within management’s expectations.
 
The following table summarizes the revenue from customers in excess of 10% of total revenue:
 
    
December 31,

 
    
2001

      
2000

 
Customer A
  
 
    
29
%
Customer B
  
 
    
11
%
Customer C
  
 
    
11
%
Customer D
  
14
%
    
 
 
At December 31, 2001, Company D represented 21% of gross accounts receivable. At December 31, 2000, Company A represented 18% of gross accounts receivable, Company B represented 30% of gross accounts receivable and Company C represented 12% of gross accounts receivable.

2


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Property and equipment
Property and equipment, including equipment under capital leases, are stated at cost. Depreciation and amortization are determined using the straight-line method over 2 to 5 years estimated useful lives. Amortization of leasehold improvements and assets held under capital leases are computed on a straight-line basis over the shorter of the facility lease term or the estimated useful lives of the improvements. In the period assets are retired or otherwise disposed of, the costs and related accumulated depreciation and amortization are removed from the accounts, and any gain or loss on disposal is included in results of operations.
 
Major additions and improvements are capitalized, while replacements, maintenance and repairs that do not improve or extend the life of the assets are charged to operations.
 
Accounting for long-lived assets
The Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability is measured by comparison of the carrying amount to the future net cash flows, which the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the projected discounted future cash flows arising from the asset.
 
Software development costs
Costs related to research and development of new software products are charged to research and development expenses as incurred. Software development costs are capitalized beginning when a product’s technological feasibility has been established, which to date has been when the Company has a working model of the software, and ending, when a product is available for general release to customers. Substantially all development costs are incurred prior to establishing a working model. As a result, the Company has not capitalized any software development costs since such costs have not been significant.
 
Income taxes
Income taxes are accounted for using an asset and liability approach, which requires the recognition of current taxes payable or refundable and deferred tax liabilities and assets for the future tax consequences of events that have been recognized in the Company’s financial statements or tax returns. The measurement of current and deferred tax liabilities and assets are based on provisions of the enacted tax law; the effects of future changes in tax laws or rates are not anticipated. The Company provides a valuation allowance for deferred tax assets when it is more likely than not, based on available evidence, that some portion or all of the deferred tax assets will not be realized. Income tax expense is the sum of the tax currently payable and the change in deferred tax assets and liabilities during the period.
 
Stock-based compensation
The Company uses the intrinsic value method to record stock-based compensation for employees, which requires that deferred stock-based compensation be recorded for the difference between an option’s exercise price and fair value of the underlying common stock on the grant date of the option. Pro forma net loss disclosures are presented in Note 10, which assume all employee options were valued using the minimum value method and the resulting stock-based compensation is amortized to expense over the estimated term of the option, generally four years, using a method which results in recording the compensation expense on an accelerated basis. Stock options for stock issued to non-employees have been accounted for in accordance with the provisions of SFAS No. 123 and Emerging Issues Task Force Issue No. 96-18, “Accounting for Equity Instruments that are Issued to Other Than Employees for Acquiring, or in Conjunction with Selling, Goods or Services.” Stock-based compensation to non-employees is based on the fair value of the equity granted estimated using the Black-Scholes model on the date of vesting. Compensation expense resulting from non-employee options is also amortized to expense using a method which results in recording the compensation expense on an accelerated basis.

3


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Advertising
In 2001 and 2000, the Company recorded advertising expense of $42,247 and $107,146, respectively. Such expenses are recognized as the related advertising is incurred.
 
Comprehensive loss
Comprehensive loss is defined as the change in equity of a business enterprise during a period from transactions and other events and circumstances from non-owner sources. There were no differences between net loss for 2001 and 2000 and comprehensive loss.
 
Recent accounting pronouncements
In August 2001, the FASB issued SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” which is effective for fiscal years beginning after December 15, 2001. SFAS No. 144 supersedes SFAS No. 121, “Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed.” The Company anticipates that implementation of this statement will not have a material impact on its financial position and results of operations.
 
In November 2001, the Emerging Issues Task Force (“EITF”) reached consensus on EITF No. 01-09, “Accounting for Consideration Given by a Vendor to a Customer or a Reseller of the Vendor’s Products.” EITF No. 01-09 addresses the accounting for consideration given by a vendor to a customer and is codification of EITF No. 00-14, “Accounting for Certain Sales Incentives,” EITF No. 00-22 “Accounting for ‘Points’ and Certain Other Time-Based or Volume-Based Sales Incentives Offers and Offers for Free Products or Services to be Delivered in the Future” and EITF No. 00-25, “Vendor Income Statement Characterization of Consideration Paid to a Reseller of the Vendor’s Products.” This EITF will be applied in financial reporting periods beginning after December 15, 2001. The Company does not believe that the adoption of this EITF will have a material impact on its financial position and results of operations.
 
In November 2001, the EITF released EITF 01-14, “Income Statement Characterization of Reimbursements Received for Out of Pocket Expenses Incurred.” The FASB concluded that reimbursements received for out of pocket expenses incurred should be characterized as revenue in the income statement. Historically, the Company has recorded reimbursements as a reduction of service cost of revenue. This EITF will be applied in financial reporting periods beginning after December 15, 2001, and comparative financial statements for prior periods will be reclassified to comply with the guidance in this EITF. The Company believes the adoption of this pronouncement will not result in a material increase of service revenue and cost of services revenue.
 
3.
 
Selected Balance Sheet Information
 
Accounts receivable
    
2001

    
2000

 
Accounts receivable
  
$
1,576,058
 
  
$
2,579,094
 
Less: Allowance for doubtful accounts
  
 
(69,925
)
  
 
(117,925
)
    


  


    
$
1,506,133
 
  
$
2,461,169
 
    


  


4


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Property and equipment
 
    
2001

    
2000

 
Furniture
  
$
640,940
 
  
$
636,947
 
Leasehold improvements
  
 
801,980
 
  
 
822,164
 
Equipment and software
  
 
2,413,329
 
  
 
2,326,749
 
    


  


    
 
3,856,249
 
  
 
3,785,860
 
Less: Accumulated depreciation
  
 
(2,131,951
)
  
 
(693,374
)
    


  


    
$
1,724,298
 
  
$
3,092,486
 
    


  


 
Property and equipment include $507,555 of equipment under capital leases for both 2001 and 2000. Accumulated amortization of assets under capital leases totaled $197,120 and $163,845 at December 31, 2001 and 2000, respectively.
 
Accrued liabilities
    
2001

  
2000

Accrued vacation
  
$
218,062
  
$
338,328
Accrued professional fees
  
 
629,259
  
 
971,580
Accrued commissions
  
 
219,965
  
 
255,778
Accrued royalty
  
 
600,000
  
 
—  
Accrued other
  
 
259,842
  
 
164,584
    

  

    
$
1,927,128
  
$
1,730,270
    

  

 
4.
 
Capital Lease Obligations
 
The Company has entered into capital lease agreements for certain equipment. These agreements, which expire between May 2001 and February 2003, require monthly lease payments including interest.
 
Future minimum payments under capital leases as of December 31, 2001 are as follows:
 
Period Ending December 31,

  
Capital
Leases

 
2002
  
$
244,314
 
2003
  
 
76,594
 
    


    
 
320,908
 
Less: Amounts representing interest
  
 
(19,664
)
    


Present value of minimum lease payments
  
 
301,244
 
Less: Current portion
  
 
(226,995
)
    


    
$
74,249
 
    


5


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
5.
 
Lines of Credit
 
In September 2000, the Company entered into an agreement with a financing company that provides for a revolving line of credit and an equipment line of credit (the “Lines”). Borrowings under the Lines are collateralized by all cash and cash equivalents and property and equipment of the Company. Under the Lines, the Company is required to maintain certain financial covenants. In the event that the Company does not meet the financial covenants, all remaining scheduled payments, including principal and interest, become due and payable, unless a waiver is obtained.
 
The revolving line of credit provides for a commitment of up to $1,500,000 with an interest rate based on the Prime Rate plus 1.50 percentage points. The revolving line of credit expired on September 27, 2001.
 
The equipment line of credit provides for a commitment of up to $2,500,000 for the acquisition of property and equipment. Funds can be drawn down under separate promissory notes from the total committed balance in increments of not less than $100,000. Available borrowings under the line of credit expired on March 27, 2001 and are to be repaid generally in 36 equal consecutive monthly installments from the related promissory note date, and bear interest at the U.S. Treasury note with a yield to maturity of 36 months plus 2.75 percentage points. At December 31, 2001, the Company was not in compliance with these financial covenants. As a result, the total balance outstanding under the equipment line of $1,440,530 was classified as current.
 
In conjunction with entering into the equipment line of credit, the Company granted a warrant to purchase 50,000 shares of Series C redeemable convertible preferred stock at an exercise price of $3.8458 per share. The fair value of the warrant of $120,707 is being amortized to interest expense over the term of the related promissory note. The fair value of the warrants was estimated using the Black-Scholes model using the following assumptions: volatility of 70%, risk-free interest rate of 5.9% and a contractual term of 5 years. Interest expense of $40,235 and $10,059 was recognized during the years ended December 31, 2001 and 2000, respectively. As a result of the exchange of preferred stocks described in Note 7, the Series C preferred stock warrant was converted into a common stock warrant.
 
6.
 
Commitments
 
Royalty obligation
 
On July 1, 1999, the Company entered into a license agreement (the “Agreement”) whereby it is obligated to pay royalties. The term of the agreement is one year and is automatically renewed on July 1st of each succeeding year for an additional one year term unless terminated by the Company. The royalty obligation is determined based on the following percentages of paid license revenue in one year: (i) 4% of paid license revenue up to $2 million and (ii) 1% of paid license revenue greater than $2 million up to $6 million. No additional royalty obligation is recognized on paid license revenue greater than $6 million in any one year. In addition, the Company may pay greater amounts to maintain the exclusivity of the license agreement. Minimum royalty payments to maintain exclusivity under the Agreement are to be as follows:
 
Date

  
Amount

July 1, 1999 to June 30, 2000
  
$
50,000
July 1, 2000 to June 30, 2001
  
$
500,000
July 1, 2001 to June 30, 2002
  
$
1,500,000
Thereafter
  
$
2,000,000
 
The Company recorded a royalty expense of $1,000,000 during the year ended December 31, 2001.

6


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Operating leases
The Company leases office space in California, Florida and Massachusetts under noncancelable operating leases.
 
Rent expense, including a pro rata share of the lessor’s operating costs, was $1,735,860 and $1,275,505 for the year ended December 31, 2001 and 2000, respectively.
 
Future minimum lease payments under the noncancelable operating leases at December 31, 2001 are as follows:
 
Year Ending December 31,

  
Operating Leases

2002
  
$
1,659,183
2003
  
 
650,726
Thereafter
  
 
176,302
    

    
$
2,486,211
    

 
The table above does not include minimum lease payments totaling $5,971,431 related to a lease that was renegotiated in March 2002 (see Note 13).
 
In March 2000, in conjunction with one of the Company’s office leases, the Company granted to its landlord a warrant to purchase 12,000 shares of its Series B redeemable convertible preferred stock at an exercise price of $2.78 per share. The fair value of the warrant of $24,175 was capitalized and is being amortized to rent expense over the seven year term of the lease. The fair value of these warrants was determined using the Black-Scholes model with the following assumptions: volatility of 70%, risk-free interest rate of 6.77% and a contractual term of 7 years. Additional rent expense of $3,454 and $2,302 was recognized during the years ended December 31, 2001 and 2000, respectively. As a result of the exchange of preferred stocks described in Note 7, the Series B preferred stock warrant was converted into a common stock warrant.
 
7.
 
Redeemable Convertible Preferred Stock
 
The Article of Incorporation, as amended, authorizes the Company to issue 179,369,228 shares of preferred stock. In May and June 1999, the Company sold 10,769,228 shares of Series A redeemable convertible preferred stock at a price of $0.26 per share. In January 2000, the Company sold 6,134,322 of Series B redeemable convertible preferred stock at $2.7839 per share. From August 2000 to November 2000, the Company sold 3,641,928 shares of Series C redeemable convertible preferred stock at $3.8458 per share. From September 2001 to December 2001, the Company sold 13,452,084 shares of Series D redeemable convertible preferred stock at $0.27 per share.

7


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Exchange of Preferred Stock
As a condition of the Series D preferred stock financing, each holder of the Series C, Series B or Series A of redeemable convertible preferred stock that elects to purchase at least fifty percent (50%) of such holder’s pro rata amount of the Series D redeemable convertible preferred stock offered for sale will automatically have a certain number of such holders of Series C, Series B and Series A redeemable convertible preferred stock converted into a newly authorized Series C-1, Series C-2, Series B-1, Series B-2 and Series A-1 redeemable convertible preferred stock. A holder of Series C redeemable convertible preferred stock will convert that number of shares of Series C redeemable convertible stock that may be determined by multiplying the aggregate purchase price paid for Series D redeemable convertible preferred stock by such holder by four (such product is hereinafter referred to as the “Conversion Amount”) and dividing the Conversion Amount by $3.8458. Each one share of Series C redeemable convertible preferred stock to be converted shall thus convert into 14.2437037 shares of Series C-1 redeemable convertible preferred stock.
 
After giving effect to the conversions described above, if a holder has remaining shares of Series C or Series B redeemable convertible preferred stock, such remaining shares of Series B and Series C redeemable convertible preferred stock shall be converted into an equal number of shares of Series C-1 and Series B-2 redeemable convertible preferred stock, respectively. Such shares of Series C-2 redeemable convertible preferred stock will be entitled to broad-based weighted average dilution protection based upon the total number of shares of Series D redeemable convertible preferred stock sold when the offering is completed. Such dilution protection will be based upon an issue price of $3.8458 in the case of the Series C-2 redeemable convertible preferred stock and $2.7839 in the case of the Series B-2 redeemable convertible preferred stock.
 
In addition to converting shares of Series B and Series C redeemable convertible preferred stock into shares of Series B-1, Series B-2, Series C-1 and Series C-2 redeemable convertible preferred stock, all such holder’s share of Series A redeemable convertible preferred stock, if any, shall be converted into an equal number of shares of Series A-1 redeemable convertible preferred stock. Any Existing Preferred Stockholder who holds only Series A redeemable convertible preferred stock and elects to purchase at least 50% of his, her or its pro rata amount of the Series D redeemable convertible preferred stock offered for sale shall have all of such holder’s Series A redeemable convertible preferred stock converted into an equal number of Series A-1 shares.
 
For those holders of Series A, Series B and Series C redeemable convertible preferred stock that do not participate in the Series D financing, each share of Series A, Series B and Series C convertible redeemable preferred stock will automatically convert into common stock.
 
The table below summarizes the exchange of shares by class of stock:
 
Class of Stock

  
Number of
Shares Issued and Outstanding Prior to Exchange Program

  
Number of Shares
Issued as part of the Exchange Program

     
Series A-1

  
Series B-1

  
Series B-2

  
Series C-1

  
Series C-2

  
Common
Stock

A
  
10,769,228
  
10,723,075
  
—  
  
—  
  
—  
  
—  
  
46,153
B
  
6,134,322
  
—  
  
14,712,512
  
4,972,385
  
—  
  
—  
  
840,220
C
  
3,641,928
  
—  
  
—  
  
—  
  
24,744,115
  
2,088,994
  
293,825
    
  
  
  
  
  
  
    
20,545,478
  
10,723,075
  
14,712,512
  
4,972,385
  
24,744,115
  
2,088,994
  
1,180,198
    
  
  
  
  
  
  

8


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
As a result of the exchange of preferred stocks described above, the Company recorded a deemed dividend of $1,893,790 resulting from the difference between the fair market value of common stock issuable upon conversion of preferred stock outstanding prior to the exchange program and the fair market value of common stock issuable upon conversion of preferred stock outstanding after the exchange program.
 
At December 31, 2001, redeemable convertible preferred stock comprised of the following:
 
    
Shares

  
Liquidation Amount

Series

  
Authorized

  
Outstanding

  
A-1
  
10,769,228
  
10,723,075
  
$
2,788,000
B-1
  
63,500,000
  
14,712,512
  
 
3,972,378
B-2
  
9,000,000
  
4,972,385
  
 
13,842,623
C-1
  
52,600,000
  
24,744,115
  
 
6,680,911
C-2
  
5,500,000
  
2,088,994
  
 
8,033,853
D
  
38,000,000
  
13,452,084
  
 
7,264,125
    
  
  

    
179,369,228
  
70,693,165
  
$
42,581,890
    
  
  

 
The rights, privileges and preferences of Series A-1, Series B-1, Series B-2, Series C-1, Series C-2, and Series D are as follows:
 
Conversion
Right to convert redeemable convertible preferred stock.
Each share of redeemable convertible preferred stock shall be convertible, at the option of the holder thereof, into such number of fully paid and nonassessable shares of common stock as provided herein. The number of shares of common stock to which a holder of redeemable convertible preferred stock shall be entitled upon conversion of a share of redeemable convertible preferred stock shall be determined by dividing (i) in the case of the Series A-1 redeemable convertible preferred stock, $0.26 by the Series A-1 Conversion Price in effect at the time that the certificate is surrendered for conversion, (ii) in the case of the Series B-1 redeemable convertible preferred stock, $0.27 by the Series B-1 Conversion Price in effect at the time that the certificate is surrendered for conversion, (iii) in the case of the Series B-2 redeemable convertible preferred stock, $0.27 by the Series B-2 Conversion Price in effect at the time that the certificate is surrendered for conversion, (iv) in the case of the Series C-1 redeemable convertible preferred stock, $0.27 by the Series C-1 Conversion Price in effect at the time that the certificate is surrendered for conversion, (v) in the case of the Series C-2 redeemable convertible preferred stock, $0.27 by the Series C-2 Conversion Price in effect at the time that the certificate is surrendered for conversion and (vi) in the case of the Series D redeemable convertible preferred stock, $0.27 by the Series D Conversion Price in effect at the time that the certificate is surrendered for conversion. The Series A-1, Series B-1, Series B-2, Series C-1, Series C-2 and Series D Conversion Price should initially be $0.26, $0.27, $0.27, $0.27, $0.27 and 0.27.

9


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Automatic conversion of redeemable convertible preferred stock into common stock.
Each share of redeemable convertible preferred stock shall automatically be converted into shares of common stock at the then effective applicable Conversion Price upon the earlier of (i) the date specified by agreement or written consent of holders of at least sixty-seven percent (67%) of the Series A-1 redeemable convertible preferred stock then outstanding, the Series B-1 redeemable convertible preferred stock then outstanding, the Series B-2 redeemable convertible preferred stock then outstanding, the Series C-1 redeemable convertible preferred stock then outstanding, the Series C-2 redeemable convertible preferred stock then outstanding and the Series D redeemable convertible preferred stock then outstanding, voting together as a single class and on an as-converted to common stock basis, or (ii) the closing of the sale of the Corporation’s common stock in a firm commitment, underwritten public offering registered under the Securities Act of 1933, as amended (the “1933 Act”), having aggregate proceeds to the corporation (net of underwriters’ discounts and expenses relating to the issuance) of at least $25,000,000 and a per share price to the public of at least $3.00.
 
Dividends
The holders of Series D redeemable convertible preferred stock are entitled to receive dividends at the rate of $0.0216 per share per annum on each outstanding share of redeemable convertible preferred stock prior to any other securities. Thereafter, Series A-1, Series B-1, Series B-2, Series C-1, Series C-2, are entitled to receive, when as declared by the Board of Directors and out of funds legally available, non-cumulative dividends at the annual rate of $0.22, $0.22, $0.0216, $0.308, $0.0216, and $0.308 per share respectively. No dividends or other distributions shall be made with respect to common stock, until all declared dividends on the Series A-1, Series B-1, Series B-2, Series C-1, Series C 2, and Series D redeemable convertible preferred stock have been paid. Through December 31, 2001, no dividends have been declared or paid by the Company.
 
Voting rights
Holder of Series A-1 redeemable convertible preferred stock, Series B-1 redeemable convertible preferred stock, Series B-2 redeemable convertible preferred stock, Series C-1 redeemable convertible preferred stock, Series C-2 redeemable convertible preferred stock and Series D redeemable convertible preferred stock are entitled to the number of votes equal to the number of shares of common stock into which such shares of each respective redeemable convertible preferred stock could be converted.
 
Liquidation preference
In the event of any liquidation, dissolution, or winding up of the Company either voluntary or involuntary, holders of Series D is entitled to receive $0.54 per share, plus any declared but unpaid dividends prior and in preference to any distribution of any assets or surplus to all other redeemable convertible preferred stock. Thereafter, holders of Series A-1, Series B-1, Series B-2, Series C-1 and Series C-2 are entitled to receive in preference over holders of common stock, an amount equal to $0.26 per share for Series A-1 redeemable convertible preferred stock, $0.27 per share for Series B-1 redeemable convertible preferred stock, $2.7839 per share for Series B-2 redeemable convertible preferred stock, $0.27 per share for Series C-1 redeemable convertible preferred stock, and $3.8458 per share for Series C-2 redeemable convertible preferred stock, plus any declared but unpaid dividends.
 
8.
 
Common Stock
 
The articles of incorporation, as amended, authorize the Company to issue 220,000,000 shares of $0.0001 par value common stock.

10


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
The Company has reserved shares of common stock for the following:
 
    
December 31,

    
2001

  
2000

Stock option plan
  
7,100,000
  
7,100,000
Conversion of Series A
  
—  
  
10,769,228
Conversion of Series A-1
  
10,769,228
  
—  
Conversion of Series B
  
—  
  
6,500,000
Conversion of Series B-1
  
63,500,000
  
—  
Conversion of Series B-2
  
9,000,000
  
—  
Conversion of Series C
  
—  
  
6,600,000
Conversion of Series C-1
  
52,600,000
  
—  
Conversion of Series C-2
  
5,500,000
  
—  
Conversion of Series D
  
38,000,000
  
—  
Common stock warrants
  
62,000
  
—  
    
  
    
186,531,228
  
30,969,228
    
  
 
Common stock issued to founders and stock issued under option exercises are subject to repurchase. At December 31, 2001 and 2000, 1,371,238 and 11,493,688 shares of common stock were subject to repurchase at a weighted average repurchase price of $0.12 and $0.042 per share, respectively. During 2001, the Company repurchased 683,251 shares of common stock at a price ranging from $0.05 to $0.77 resulting in $40,431 charged to operating expense.
 
Common stock warrants
A table summarizing all warrants to purchase common stock is below:
 
Issue Date

  
Term (Years)

  
Exercise Price

  
Number of Shares

  
Fair Value

  
Expense Recognized in 2001

  
Expense Recognized in 2000

May 2000
  
7.0
  
$
2.78
  
12,000
  
$
24,175
  
$
3,454
  
$
2,302
September 2000
  
5.0
  
$
3.8658
  
50,000
  
 
120,707
  
 
40,235
  
 
10,059
                
  

  

  

                
62,000
  
$
144,882
  
$
43,689
  
$
12,361
                
  

  

  

 
9.
 
Notes Receivable
 
During 2000 and 1999, the Company accepted promissory notes from employees and investors totaling $242,549 and $46,507, respectively, to finance their purchase of stock. Interest on the notes is computed at an annual rate of 8.25% to 9.50%. Accrued interest is due at maturity, which varies from note to note through November 2003. These notes are included in stockholders’ deficit. In 2001, total payments of promissory notes amounted to $209,652.

11


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
10.
 
Stock Options
 
On June 18, 1999, the Company’s stockholders adopted the 1999 Stock Option/Stock Incentive Plan (the “Option Plan”), as amended. Under the Option Plan, options to purchase up to 7,100,000 shares of common stock may be granted to directors, officers and employees of and advisors to the Company at an exercise price not less than 100% of the fair value (as determined by the Board of Directors) of the Company’s common stock on the date of grant for incentive stock options and not less than 85% of the fair value of the Company’s common stock on the date of grant for nonqualified stock options. If options are granted to stockholders who hold 10% or more of the Company’s common stock on the option grant date, then the exercise price shall not be less than 110% of the fair value of the Company’s common stock on the date of grant for both incentive and nonqualified stock option grants. These options have exercise prices, early exercise rights and vesting terms established by the Board of Directors at the time of each grant. Option grants to a new employee under the Plan generally vest 25% at the first anniversary of the hire date with the remaining being vested monthly for the following three years. In no event are options exercisable more than 10 years after the date of grant for both incentive and nonqualified stock options.
 
Activity under the Option Plan is as follows:
 
    
Options Outstanding

    
Shares
Available
for Grant

    
Number of
Shares
Outstanding

    
Weighted
Average
Exercise
Price

Balance, December 31, 1999
  
1,973,000
 
  
2,667,000
 
  
$
0.05
Options authorized
  
1,500,000
 
  
—  
 
  
 
—  
Options granted
  
(2,699,742
)
  
2,699,742
 
  
 
0.56
Options exercised
  
—  
 
  
(3,495,700
)
  
 
0.16
Options cancelled
  
195,000
 
  
(195,000
)
  
 
0.58
Common stock repurchased
  
116,875
 
  
—  
 
  
 
0.30
    

  

      
Balance, December 31, 2000
  
1,085,133
 
  
1,676,042
 
  
$
0.88
Options authorized
  
—  
 
  
—  
 
  
 
—  
Options granted
  
(1,554,568
)
  
1,554,568
 
  
 
0.38
Options exercised
  
—  
 
  
(77,542
)
  
 
0.51
Options cancelled
  
889,546
 
  
(889,546
)
  
 
0.65
Common stock repurchased
  
683,251
 
  
—  
 
  
 
0.18
    

  

      
Balance, December 31, 2001
  
1,103,362
 
  
2,263,522
 
  
$
0.42
    

  

      

12


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
The following table summarizes information about stock options outstanding and exercisable at December 31, 2001:
 
 
    
Options Outstanding and Exercisable

  
Options Exercisable

Exercise Price

  
Number Outstanding

    
Weighted Average Remaining Contractual Life (Years)

  
Weighted Average Exercise Price

  
Number Exercisable

  
Weighted Average Exercise Price

$0.05
  
871,500
    
8.9
  
$
0.05
  
871,500
  
$
0.05
$0.56
  
790,778
    
8.3
  
$
0.56
  
490,778
  
$
0.56
$0.77
  
601,244
    
9.2
  
$
0.77
  
592,344
  
$
0.77
    
    
  

  
  

    
2,263,522
    
8.7
  
$
0.42
  
1,954,622
  
$
0.40
    
    
  

  
  

 
At December 31, 2000, 160,583 shares under outstanding options were vested at a weighted average price of $0.12.
 
Deferred stock-based compensation
The Company has adopted the disclosure-only provisions of SFAS No. 123, “Accounting for Stock-Based Compensation.” The Company, however, continues to apply APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for its Option Plan.
 
In connection with certain consultant stock option grants, the Company recorded stock-based compensation of $23,747 during the year ended December 31, 2001.
 
Fair value disclosures
Had compensation cost of Cybrant’s stock-based compensation awards been determined based on the minimum value at the grant dates as prescribed by SFAS No. 123, the Company’s net loss would have been as follows:
 
    
Year Ended December 31,

 
    
2001

    
2000

 
Net loss:
                 
As reported
  
$
(14,676,381
)
  
$
(20,321,129
)
Pro forma
  
$
(14,728,046
)
  
$
(20,447,532
)

20


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Under SFAS No. 123, the minimum value of each option grant is estimated on the grant date using the following weighted average assumptions:
 
    
Year Ended December 31,

 
    
2001

      
2000

 
Expected lives in years
  
4
 
    
4
 
Risk-free interest rates
  
4.63
%
    
6.39
%
Dividend yield
  
0.0
%
    
0.0
%
 
11.
 
Income Taxes
 
Deferred tax assets (liabilities) consist of the following:
 
    
December 31,

 
    
2001

    
2000

 
Deferred tax assets:
                 
Depreciation and amortization
  
$
150,000
 
  
$
233,000
 
Allowances and accruals
  
 
136,000
 
  
 
135,000
 
Tax carryforward
  
 
1,006,000
 
  
 
338,000
 
Net operating loss carryforwards
  
 
13,687,000
 
  
 
7,646,000
 
    


  


    
 
14,979,000
 
  
 
8,352,000
 
Deferred tax liability
  
 
—  
 
  
 
—  
 
    


  


Gross deferred tax asset
  
 
14,979,000
 
  
 
8,352,000
 
Valuation allowance
  
 
(14,979,000
)
  
 
(8,352,000
)
    


  


    
$
—  
 
  
$
—  
 
    


  


 
Based on the available objective evidence, management believes it is more likely than not that the net deferred tax assets will not be fully realizable. Accordingly, the Company has provided a full valuation allowance against its net deferred tax assets at December 31, 2001.
 
As of December 31, 2001, the company had approximately $35.2 million and $29.7 million of federal and state net operating loss carryforwards available to offset future taxable income, respectively. If not utilized, these carryforwards will begin to expire beginning in 2019 through 2021 for federal and 2007 through 2011 for state purposes.
 
The Company also has research and development tax credit carryforwards of approximately 724,000 and $427,000 for federal and state income tax purposes, respectively. If not utilized, the federal carryforwards will expire in various amounts beginning in 2019. The state tax credits can be carried forward indefinitely.
 
Under the Internal Revenue Code Section 382, the amounts of and benefits from net operating loss carryforwards may be impaired or limited in certain circumstances. Events which cause limitations in the amount of net operating losses that the Company may utilize in any one year include, but are not limited to, a cumulative ownership change of more that 50%, as defined, over a three year period.

14


The Cybrant Corporation
Notes to Financial Statements (Continued)

 
Due to the uncertainty surrounding the realization of favorable tax attributes in future tax returns, the Company has placed a valuation allowance against its deferred tax assets. At such time as it is determined that it is more likely than not that the deferred tax assets are realizable, the valuation allowance will be reduced.
 
12.
 
401(k) Plan
 
In August 2000, the Company adopted a 401(k) defined contribution plan (the “Plan”), which covers substantially all employees of the Company, as defined by the Plan. The Company has the option of matching a percentage of employee contributions to the Plan at a percentage set by the Company’s Board of Directors, at their discretion. The Company has not made any contributions to the Plan since its adoption.
 
13.
 
Subsequent Events
 
Merger with Blue Martini Software
On April 16, 2002, the Company entered into a definitive Agreement and Plan of Merger and Reorganization (“the Agreement”) with Blue Martini Software, Inc. Under the terms of the Agreement, the Company merged with Blue Martini effective April 16, 2002.
 
Lease termination
In March 2002, the Company entered into an amendment to its office lease agreement located in California to reduce the office space and the remaining term of the lease agreement. The minimum payments under the amended one year lease total $80,820. The Company paid $499,776 and granted the landlord a warrant to purchase 1,250,000 shares of Series D redeemable convertible preferred stock with an exercise price of $0.27 per share for the amendment. The warrant has a contractual life of five years and will expire on March 2007.
 
Warrants
In January 2002, in conjunction with the amendment of certain provisions of the line of credit, the Company granted a warrant to purchase 477,685 shares of Series D redeemable preferred stock at an exercise price of $0.27 per share. The warrant has a contractual life of five years and all will expire in January 2007.

15
-----END PRIVACY-ENHANCED MESSAGE-----